Increased statin eligibility based on ACC/AHA versus NCEP guidelines for high cholesterol management in Chile

Journal of Clinical Lipidology

Volumn 10, Issue 1, 2016, Pages 192-198.e1

  Echeverría, Guadalupe ^a   Dussaillant, Catalina ^a   Villarroel, Luis ^a   Rigotti, Attilio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Cardiovascular risk; Guidelines; LDL cholesterol; Statin therapy eligibility

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CHILE; CHILEAN; CROSS-SECTIONAL STUDY; FEMALE; GENDER; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; CARDIOLOGY; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; HEALTH SURVEY; METABOLISM; PATIENT SELECTION; RISK; SEX DIFFERENCE; UNITED STATES;

ADULT; AGE FACTORS; AMERICAN HEART ASSOCIATION; CARDIOLOGY; CARDIOVASCULAR DISEASES; CHILE; CHOLESTEROL; FEMALE; HEALTH SURVEYS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK; SEX FACTORS; UNITED STATES;

EID: 84958856617     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.11.008     Document Type: Article

References (21)

1. G. De Backer, E. Ambrosioni, K. Borch-Johnsen, and et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts) Arch Mal Coeur Vaiss 97 10 2004 1019 1030
2. Expert Panel on Detection E Treatment of High Blood Cholesterol in A Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 19 2001 2486 2497
3. S.M. Grundy, J.I. Cleeman, C.N. Merz, and et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2 2004 227 239
4. A. Cuevas, A. Arteaga, and A. Rigotti A Latin American perspective on the new ACC/AHA clinical guidelines for managing atherosclerotic cardiovascular disease Curr Atheroscler Rep 16 4 2014 400
5. R. Rojas, C.A. Aguilar-Salinas, F.J. Gomez-Perez, and et al. Applicability of the National Cholesterol Education Program III (NCEP-III) guidelines for treatment of dyslipidemia in a non-Caucasian population: a Mexican nation-wide survey Rev Invest Clin 57 1 2005 28 37
6. K. Nasir, R.D. Santos, A. Roguin, J.A. Carvalho, R. Meneghello, and R.S. Blumenthal Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men Int J Cardiol 108 1 2006 68 75
7. C. Olivos, A. Valenzuela, A. Arteaga, and et al. Po16-425 Cardiovascular risk, cholesterol goal attainment, and lipid-lowering eligibility in Chile. Findings from the First National Health Survey Atheroscler Suppl 8 1 2007 121 122
8. F.J. Gomez-Perez, R. Rojas, S. Villalpando, S. Barquera, J. Rull, and C.A. Aguilar-Salinas Prevention of cardiovascular disease based on lipid lowering treatment: a challenge for the Mexican health system Salud Publica Mex 52 Suppl 1 2010 S54 S62
9. R.D. Santos, D.D. Waters, L. Tarasenko, and et al. A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: the Lipid Treatment Assessment Project 2 Atherosclerosis 224 1 2012 150 153
10. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 25 Pt B 2014 2889 2934
11. M.J. Pencina, A.M. Navar-Boggan, R.B. D'Agostino Sr., and et al. Application of new cholesterol guidelines to a population-based sample N Engl J Med 370 15 2014 1422 1431
12. M. Kavousi, M.J. Leening, D. Nanchen, and et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort JAMA 311 14 2014 1416 1423
13. Chilean Ministry of Health. Second Chilean National Health Survey 2009-2010. Available at: http://web.minsal.cl/portal/url/item/bcb03d7bc28b64dfe040010165012d23.pdf. Accessed June 30, 2015.
14. G.A. Rose, and H. Blackburn Cardiovascular survey methods Monogr Ser World Health Organ 56 1968 1 188
15. S.M. Grundy, J.I. Cleeman, S.R. Daniels, and et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary Crit Pathw Cardiol 4 4 2005 198 203
16. P.M. Ridker, and N.R. Cook Statins: new American guidelines for prevention of cardiovascular disease Lancet 382 9907 2013 1762 1765
17. J.F. Keaney Jr., G.D. Curfman, and J.A. Jarcho A pragmatic view of the new cholesterol treatment guidelines N Engl J Med 370 3 2014 275 278
18. K.N. Karmali, D.C. Goff Jr., H. Ning, and D.M. Lloyd-Jones A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease J Am Coll Cardiol 64 10 2014 959 968
19. M.D. Miedema, F.L. Lopez, M.J. Blaha, and et al. Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort JAMA Intern Med 175 1 2015 138 140
20. N.R. Cook, and P.M. Ridker Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study JAMA Intern Med 174 12 2014 1964 1971
21. J. Yeboah, S. Sillau, J.C. Delaney, and et al. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA) Am Heart J 169 3 2015 387 395.e383